Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
Código da empresaSNOA
Nome da EmpresaSonoma Pharmaceuticals Inc
Data de listagemJan 26, 2007
CEOMs. Amy Trombly
Número de funcionários168
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 26
Endereço5445 Conestoga Court, Suite 150
CidadeBOULDER
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal80301
Telefone18007599305
Sitehttps://sonomapharma.com/
Código da empresaSNOA
Data de listagemJan 26, 2007
CEOMs. Amy Trombly
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados